Literature DB >> 12082107

The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases.

Bo Zhou1, Zhi-Xin Wang, Yu Zhao, David L Brautigan, Zhong-Yin Zhang.   

Abstract

The extracellular signal-regulated protein kinase 2 (ERK2) is the founding member of a family of mitogen-activated protein kinases (MAPKs) that are central components of signal transduction pathways for cell proliferation, stress responses, and differentiation. The MAPKs are unique among the Ser/Thr protein kinases in that they require both Thr and Tyr phosphorylation for full activation. The dual phosphorylation of Thr-183 and Tyr-185 in ERK2 is catalyzed by MAPK/ERK kinase 1 (MEK1). However, the identity and relative activity of protein phosphatases that inactivate ERK2 are less well established. In this study, we performed a kinetic analysis of ERK2 dephosphorylation by protein phosphatases using a continuous spectrophotometric enzyme-coupled assay that measures the inorganic phosphate produced in the reaction. Eleven different protein phosphatases, many previously suggested to be involved in ERK2 regulation, were compared, including tyrosine-specific phosphatases (PTP1B, CD45, and HePTP), dual specificity MAPK phosphatases (VHR, MKP3, and MKP5), and Ser/Thr protein phosphatases (PP1, PP2A, PP2B, PP2C alpha, and lambda PP). The results provide biochemical evidence that protein phosphatases display exquisite specificity in their substrate recognition and implicate HePTP, MKP3, and PP2A as ERK2 phosphatases. The fact that ERK2 inactivation could be carried out by multiple specific phosphatases shows that signals can be integrated into the pathway at the phosphatase level to determine the cellular response to external stimuli. Important insights into the roles of various protein phosphatases in ERK2 kinase signaling are obtained, and further analysis of the mechanism by which different protein phosphatases recognize and inactivate MAPKs will increase our understanding of how this kinase family is regulated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082107     DOI: 10.1074/jbc.M203969200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  88 in total

1.  Selective deficiency in protein kinase C isoenzyme expression and inadequacy in mitogen-activated protein kinase activation in cord blood T cells.

Authors:  Charles S T Hii; Maurizio Costabile; George C Mayne; Channing J Der; Andrew W Murray; Antonio Ferrante
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  Inhibition of hematopoietic protein tyrosine phosphatase augments and prolongs ERK1/2 and p38 activation.

Authors:  Eduard Sergienko; Jian Xu; Wallace H Liu; Russell Dahl; David A Critton; Ying Su; Brock T Brown; Xochella Chan; Li Yang; Ekaterina V Bobkova; Stefan Vasile; Hongbin Yuan; Justin Rascon; Sharon Colayco; Shyama Sidique; Nicholas D P Cosford; Thomas D Y Chung; Tomas Mustelin; Rebecca Page; Paul J Lombroso; Lutz Tautz
Journal:  ACS Chem Biol       Date:  2011-11-17       Impact factor: 5.100

3.  Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells.

Authors:  George D Dalton; Allyn C Howlett
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

4.  A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity.

Authors:  Ping-Yuan Wang; Pingsheng Liu; Jian Weng; Estelle Sontag; Richard G W Anderson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

5.  Long-term effect of heat shock protein 60 from Actinobacillus actinomycetemcomitans on epithelial cell viability and mitogen-activated protein kinases.

Authors:  Liangxuan Zhang; Steven Pelech; Veli-Jukka Uitto
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling.

Authors:  Mariko Hatakeyama; Shuhei Kimura; Takashi Naka; Takuji Kawasaki; Noriko Yumoto; Mio Ichikawa; Jae-Hoon Kim; Kazuki Saito; Mihoro Saeki; Mikako Shirouzu; Shigeyuki Yokoyama; Akihiko Konagaya
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

7.  Glycine N-methyltransferase expression in the hippocampus and its role in neurogenesis and cognitive performance.

Authors:  Manuel Carrasco; Luis G Rabaneda; Maribel Murillo-Carretero; Sylvia Ortega-Martínez; María L Martínez-Chantar; Ashwin Woodhoo; Zigmund Luka; Conrad Wagner; Shelly C Lu; José M Mato; Juan A Micó; Carmen Castro
Journal:  Hippocampus       Date:  2014-04-08       Impact factor: 3.899

8.  Specificity profiling of dual specificity phosphatase vaccinia VH1-related (VHR) reveals two distinct substrate binding modes.

Authors:  Rinrada Luechapanichkul; Xianwen Chen; Hashem A Taha; Shubham Vyas; Xiaoyan Guan; Michael A Freitas; Christopher M Hadad; Dehua Pei
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

9.  Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38alpha in different phosphorylation states.

Authors:  Yuan-Yuan Zhang; Zi-Qing Mei; Jia-Wei Wu; Zhi-Xin Wang
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

10.  Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.

Authors:  Matthew S Kelker; Rebecca Page; Wolfgang Peti
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.